Skip to main content

From The Master

 I keep coming across this sentiment from Warren Buffet (if you are unsure who he is, Google him and be amazed). It goes a bit like this:

The stock market is about transferring money from the impatient to the patient.

It has been quoted a number of different ways, but the basic idea remains. And I agree. There are plenty of times when sitting on my hands and being patient paid huge returns, and that continues in my current portfolio.

Yes, I love the interplay of finding a new stock, making a quick profit and then finding another new stock. For me, that's interesting and fun.

But I also appreciate the times when you find a stock and hang on to it for as long as you can to get maximum benefit, and right now I have 2 of those: DTR and BOT. DTR is a sleeper (as I have said beofre) but should turn into a monster (from a base of, currently, 0.5 cents). BOT is ready to jump, just as soon as sales results hit at the end of 2024.

Now, it is unwise to go off my timing, and wise to figure your own dates. Let me tell you why.

Late in 2023, I identified PAA as a likely target for a profit. I picked early Feb 2024 as the date to get in because there were results due in mid-February. However, the results came out in late January and the stock soared 400%. Yep, I missed that one.

So make sure you do your own research.

Labels:

Comments

Post a Comment

Popular posts from this blog

A Couple of Updates

 Well, it's Monday morning and the week has started with a bang. First, PFE announced that there was an unexpected problem with their test drill and they have had to abandon that and go to a new test drill site. A delay, but no real issue apart from that. And the market hated that. Good news for those wanting to buy, not so good for existing holders. IMC released their AGM presentation which indicates that there will be some news in December and then a very busy (and hopefully productive) 2025. Sales are good and continuing to get better and better.
Post a Comment
Read more

2025 - an early start

 Ok., so here we go on my Trump-era goal. Just bought MXR (yes, on the ASX). AAR wants to take them over at 7 cents as a scrip payment (paying in AAR shares instead of cash). The current share price is 6.3 cents. So that should be a quick 10% gain. However... this does look like a lowball offer and may yet be increased. MXR has great assets and AAR already owns almost 20% of MXR. So AAR is committed to a deal and that may just attract other attention. It looks like a no-brainer to start 2025. Yes, there is always some risk, but this one looks pretty good. I have done a bit more research and have some exciting thoughts, including one that looks a little like another WGO (which returned handsomely on a takeover). More news coming as I do more reseach.  Another one that looks good for a quick profit is GES, but as I write this, there are no shares at the right price (.05).
Post a Comment
Read more

Out of 2

 I ahd some bills to pay and these 2 got the chop: PFE - such promise, such disappointmen IMC - I always had some ethical problems with this one.  But there it is. Bills paid, and a little left over to find something new with. 
Post a Comment
Read more